EGFR and neoplasm: The metabolic reprogramming mediated by the aberrant expression of EGFR, which can improve the pentose phosphate pathway and aerobic glycolysis to promote DNA repair and apoptosis resistance, is an efficient oncogenic defense mechanism of tumor cells [73,74].